Login or sign up
For business

Inflection Biosciences

4.3Β· 12 reviews
Average ratingGreat
4.3/ 5

Based on 12 reviews

550%
425%
325%
20%
10%
Ask AI

Ask AI about Inflection Biosciences

Generated with AI from 12 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website β€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Inflection Biosciences

Inflection Biosciences is an early stage, drug development company with a focus on developing innovative small molecule therapeutics that address major unmet needs in
cancer.

With bases in Dublin and London, the company is dedicated to identifying excellent early stage cancer research from academic institutes and companies around the world. Inflection
Biosciences will use its expertise to progress the most promising programs through pre-clinical and early clinical stages, partnering with larger.

pharma for later stage clinical development and commercialisation.

The company’s founders, including CEO Darren Cunningham and Director of R&D Dr. Michael O’Neill, bring over 60 years of industry experience along with access to a global
network of potential partners and service providers.

Address
Anglesea House, Carysfort Avenue, Blackrock, Co. Dublin, Ireland